Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03904108
Title Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors ROGER S MD KERESZTES
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stony Brook University Stony Brook New York 11794 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field